Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I say AUPH'll drop to $2 like ARIA and then bankrupt even if P3 is halted and the LN drug is approved earlierby the FDA. I do have things to do with AUPH. Why do you ask?
If it falls below $6, I'll liquidate all my 3 shares in 6 accounts and short hard again. I liquidated at $5.99 all my previous 3 shares in 6 accounts and shorted hard. I can afford to short as many as 2 shares since I have made a fortune from joining a class action lawsuit against Ariad. I received $0.001 per 1,000 ARIA shares I sold at $2.xx, which is more than enough to cover the cost for borrowing 2 shares to short. I was/am honest about my ARIA/AUPH positions. You would be a fool if you didn't believe me.
Selling my 0 AUPH shares at $79.75-$79.86 after the AUPH-buyout-at-$80 news is announced I will claim. I had been saying ARIA would drop to $2 and then it would bankrupt before I claimed I sold at $23.75-$23.86 on the ARIA-buyout-at-$24 news.
Why double-blinded? Cuz phase 2 shows particular promise (amazingly good data). A double-blinded study is used after initial studies show particular promise, which is defined by MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and we made millions on ARIA. We will make more on AUPH.
Quote: "Nothing but the clinical trial data are the determinants. I infer about the success of Voclosporin's phase 3 not that it is double-blinded but that its design is almost identical to phase 2, which has delivered amazingly good data. And it is believed that Phase 3 results will be even stronger than Phase 2 because better selection of clinical trial sites & healthier patients. A double-blinded study is used after initial studies show particular promise. Voclosporin's phase 2 study has shown particular promise (amazingly good results). That's why its phase 3 study is double-blinded."
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
Why double-blinded? Cuz phase 2 shows particular promise (amazingly good data). A double-blinded study is used after initial studies show particular promise, which is defined by MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and we made millions on ARIA. We will make more on AUPH.
Quote: "Nothing but the clinical trial data are the determinants. I infer about the success of Voclosporin's phase 3 not that it is double-blinded but that its design is almost identical to phase 2, which has delivered amazingly good data. And it is believed that Phase 3 results will be even stronger than Phase 2 because better selection of clinical trial sites & healthier patients. A double-blinded study is used after initial studies show particular promise. Voclosporin's phase 2 study has shown particular promise (amazingly good results). That's why its phase 3 study is double-blinded."
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
I will claiming selling my ZERO AUPH shares at $79.75-$79.86 after the AUPH-buyout-at-$80 news is announced. I had been saying ARIA would drop to $2 and then it would bankrupt before I claimed I sold at $23.75-$23.86 on the ARIA-buyout-at-$24 news.
"Clearly the FDA has protocol set up for looking in at blinded P3 studies," says tiv111. "From what I've read on DMC outcomes voc seems like an ideal candidate for action. If the 24 week P3 data for example looks to be as strong as the P2 results how can you in good conscience continue to give someone a placebo when you know that voc is working. This is a life and death situation for some patients. " - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132795597 and http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132779749
- Posted by ariadinvestor:
https://finance.yahoo.com/quote/Auph/community?p=Auph
"voc seems like an ideal candidate for action. If the 24 week P3 data for example looks to be as strong as the P2 results how can you in good conscience continue to give someone a placebo when you know that voc is working. This is a life and death situation for some patients. What I need to research is if a DMC interim look is automatic or does it have to be set up as part of the trial design. "
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132795597
The difference is AUPH is a blinded trial for 2 years, I repeat no data, and Ariad had interim trial results as the data matured,
I had been bashing Ariad before it was bought out. I had been saying ARIA would drop to $2 and then it would bankrupt before I claimed I sold at $23.75-$23.86 on the ARIA buyout news. Although I have been basing AUPH the way I bashed ARIA, I will be claiming my selling my ZERO AUPH shares at $79.75-$79.86 after the AUPH-buyout-at-$80 news is announced. Who dare to say I am a pathetic basher/liar? Who am I? Please don't say I am the well known VIP/basher.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132472979
Halting the trial early is not likely, I repeat. There is no, I repeat no, interim analysis. AUPH will drop to $2 like ARIA and then bankrupt even if P3 is halted and the LN drug is approved by the FDA earlier, I repeat. AUPH will drop to $2 and then bankrupt, I repeat.
AUPH will drop to $2 like ARIA and then bankrupt even if P3 is halted and the LN drug is approved by the FDA. AUPH will drop to $2 and then bankrupt, I repeat.
Phase 3 will succeed not that it is double-blinded but that its design is almost identical to phase 2, which has delivered amazingly good data. And it is believed that Phase 3 results will be even stronger than Phase 2 because better selection of clinical trial sites & healthier patients. A double-blinded study is used after initial studies show particular promise. Voclosporin's phase 2 study has shown particular promise (amazingly good results). That's why its phase 3 study is double-blinded. - This is posted by ariadinvestor on 06/29/2017.
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
Lunacy: "Phase 3 results will be even stronger than Phase 2b because better selection of clinical trial sites and healthier patients.
https://www.scribd.com/document/351501581/Aurinia-Pharmaceutical-AUPH-is-Severely-Undervalued
AUPH is severely undervalued - Takeover prospects and update on current Phase III enrollment.
Source: https://www.scribd.com/document/351501581/Aurinia-Pharmaceutical-AUPH-is-Severely-Undervalued
Lunacy: "Phase 3 results will be even stronger than Phase 2b because better selection of clinical trial sites and healthier patients.
AI:"Pls tell Jesspro AUPH will be my next ARIA."
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
JessPro: "Thanks Granma for the very informative post. AriadInvestor is the guy that racked up the most profit in Ariad. I know he'll do the same thing with Auph. GL to us."
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132513995
Double-blinded studies are often used when initial studies shows particular promise, which is true, not new. MedicineNet.com says so while explaining what double-blinded studies are., Voclosporin's phase 2 study has shown particular promise (amazingly great results), that's why its phase 3 study is double-blinded. Aurinia has very bright future. Patience is the key to the big success of a faithful AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. They had patience and they made millions on ARIA. They will make more on AUPH.
Link: http://www.medicinenet.com/script/main/art.asp?articlekey=11177
I bought AUPH advised by Vid. He is in Jailhouse now. Let's hope he'll be set free soon.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131578413
Lunacy: "Phase 3 results will be even stronger than Phase 2b because better selection of clinical trial sites and healthier patients.
https://www.scribd.com/document/351501581/Aurinia-Pharmaceutical-AUPH-is-Severely-Undervalued
The difference is AUPH is a blinded trial for 2 years, no data, and Ariad had interim trial results as the data matured.
I had been bashing Ariad before it was bought out. I had been saying ARIA would drop to $2 and then it would bankrupt before I claimed I sold at $23.75-$23.86 on the ARIA buyout news. Although I have been basing AUPH the way I bashed ARIA, I will be claiming my selling my ZERO AUPH shares at $79.75-$79.86 after the AUPH-buyout-at-$80 news is announced. Who dare to say I am a pathetic basher/liar? Who am I? Please don't say I am the well known VIP/basher.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132472979
If it falls below $6, I'll liquidate all my 3 shares in 6 accounts and short hard again. I liquidated at $5.99 all my previous 3 shares in 6 accounts and shorted hard. I can afford to short as many as 2 shares since I have made a fortune from joining a class action lawsuit against Ariad. I received $0.001 per 1,000 ARIA shares I sold at $2.xx, which is more than enough to cover the cost for borrowing 2 shares to short. I was/am honest about my ARIA/AUPH positions. You would be a fool if you didn't believe me.
MedicineNet:"Double-blinded studies are used when initial studies shows particular promise." - http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.
Medical Definition of Double-blinded study: "... Double-blinded studies are often used when initial studies shows particular promise." Source: MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.
A double-blinded study is used WHEN initial trials show particular promise. Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.
A double-blinded study is used after initial studies show particular promise. Source: MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
When double-blinded studies are used? A double-blinded study is used after initial studies show particular promise. Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Vid: "Duggan would be to Aurinia what Denner was to Ariad. Max value if he gets on the board."
Araidinvestor posted 2 months ago: ""Will Robert Duggan to Aurinia be Alex Denner to Ariad? I hope so. Robert Duggan Takes a 7.2% Stake in Aurinia (5,766,887 shares @6.50-8.85, AVG price 7.50?). This is great AUPH news to me."
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
Lunacy, the VIP needs repeated copy&paste cuz he doesn't know double-blinded studies are used after initial trials show particular promise. The best way to educate him is to copy and paste of the same message everyday.
Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.
A double-blinded study is used after initial studies show particular promise. Source: MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
I liquidated @$5.99 all my 3 shares in 6 accounts. I will short hard. I can afford to short as many as 2 shares since I have made a fortune from joining a class action lawsuit against Ariad. I received $0.001 per 1,000 ARIA shares I sold at $2.xx, which is more than enough to cover the cost for borrowing 2 shares to short. I was/am honest about my ARIA/AUPH positions. You would be a fool if you didn't believe me.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131995884
It's NOT NEW but true. Double-blinded studies are used after initial studies shows particular promise. Source: MedicineNet.com . Voclosporin's phase 2 study has shown particular promise (amazingly great results), that's why its phase 3 study is double-blinded. Aurinia has very bright future. Patience is the key to the big success of a faithful AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and we made millions on ARIA. We will make more on AUPH.
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
$80>$37. "We have bottomed at around 6. May be a good opportunity to buy this week," says Vidpok45. "Bought more today." Vid did say AUPH $80: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131503122
"The phase 3 will success not that it is double-blinded but that its design is almost identical to phase 2, which has delivered amazingly good data. And it is believed that Phase 3 results will be even stronger than Phase 2 because better selection of clinical trial sites & healthier patients. A double-blinded study is used after initial studies show particular promise. Voclosporin's phase 2 study has shown particular promise (amazingly good results). That's why its phase 3 study is double-blinded. Nothing but the clinical trial data are the determinants."
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
Why double-blinded? Cuz phase 2 shows particular promise (amazingly good data). A double-blinded study is used after initial studies show particular promise, which is defined by MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and we made millions on ARIA. We will make more on AUPH.
Why double-blinded? Cuz phase 2 shows particular promise (amazingly good data). A double-blinded study is used after initial studies show particular promise, which is defined by MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and we made millions on ARIA. We will make more on AUPH.
Quote: "Nothing but the clinical trial data are the determinants. I infer about the success of Voclosporin's phase 3 not that it is double-blinded but that its design is almost identical to phase 2, which has delivered amazingly good data. And it is believed that Phase 3 results will be even stronger than Phase 2 because better selection of clinical trial sites & healthier patients. A double-blinded study is used after initial studies show particular promise. Voclosporin's phase 2 study has shown particular promise (amazingly good results). That's why its phase 3 study is double-blinded."
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
You agree double-blinded studies are used after initial trials show particular promise now? Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and we made millions on ARIA. We will make more on AUPH.
A double-blinded study is used after initial studies show particular promise. Source: MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
A double-blinded trial is used after initial trials show particular promise. Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.
A double-blinded study is used after initial studies show particular promise. Source: MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
The truth is NOT NEW. It is true that double-blinded studies are used after initial studies shows particular promise. Source: MedicineNet.com . Voclosporin's phase 2 study has shown particular promise (amazingly great results), that's why its phase 3 study is double-blinded. Aurinia has very bright future. Patience is the key to the big success of a faithful AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and we made millions on ARIA. We will make more on AUPH.
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Double-blinded studies are often used when initial studies shows particular promise, which is true, not new. MedicineNet.com says so while explaining what double-blinded studies are., Voclosporin's phase 2 study has shown particular promise (amazingly great results), that's why its phase 3 study is double-blinded. Aurinia has very bright future. Patience is the key to the big success of a faithful AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. They had patience and they made millions on ARIA. They will make more on AUPH.
Link:
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Double-blinded studies are often used when initial studies shows particular promise. Voclosporin's phase 2 study has shown particular promise (amazingly great results), that's why its phase 3 study is double-blinded. Aurinia has very bright future. Patience is the key to the big success of a faithful AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. They had patience and they made millions on ARIA. They will make more on AUPH.
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
$80. Vid:"Duggan would be to Aurinia what Denner was to Ariad. Max value if he gets on the board." Araidinvestor: https://finance.yahoo.com/quote/AUPH/community?p=AUPH" rel="nofollow" target="_blank" >https://finance.yahoo.com/quote/AUPH/community?p=AUPH"Will Robert Duggan to Aurinia be Alex Denner to Ariad? I hope so. Robert Duggan Takes a 7.2% Stake in Aurinia (5,766,887 shares @6.50-8.85, AVG price 7.50?). This is great AUPH news to me."/tag]
vidpok45: "...80 per share ..." Ronald: "... hope Bob Duggan winds up on the BOD (echoing whoever said he will insure BO achieves the max $$$." Lunacy: "Ph3 results will likely be even stronger than 2b because of the better selection of clinical trial sites with access to reasonable healthcare, and healthier patient population."
37<80. Vid:"80 per share ... in light of the high probability for the success of Voclosporin."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131504397
Voclosporin Combo Does Better Than Standard Therapy in Eliminating Lupus Nephritis, Trial Shows
https://lupusnewstoday.com/2017/06/21/trial-shows-voclosporin-combo-therapy-eliminates-lupus-nephritis-in-many-patients/
Thanks, Lunacy and Jess. A.F. says AUPH is a good company:
When $AUPH day traders become $AUPH shareholders…
— Adam Feuerstein ✡️ (@adamfeuerstein) March 13, 2017
Relax, you own a good company. pic.twitter.com/kEdb9KpG9T
$80>$37. "We have bottomed at around 6. May be a good opportunity to buy this week," says Vidpok45. "Bought more today." Vid did say AUPH $80: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131503122
Will this be deleted again? Is this off topic?
Vid: "A buyout for 2x revenue would yield 80 per share (very conservative), not counting the DES indication. That sounds pretty decent to me." Pretty decent to me, too!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=131503122